SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-22-117641
Filing Date
2022-04-25
Accepted
2022-04-25 16:31:01
Documents
6
Period of Report
2022-04-25

Document Format Files

Seq Description Document Type Size
1 6-K d626061d6k.htm 6-K 11135
2 EX-99.1 d626061dex991.htm EX-99.1 27347
3 GRAPHIC g626061g0423100317804.jpg GRAPHIC 4217
4 GRAPHIC g626061g0423100318257.jpg GRAPHIC 1542
5 GRAPHIC g626061g0423100318476.jpg GRAPHIC 1812
6 GRAPHIC g626061g0423100318757.jpg GRAPHIC 1709
  Complete submission text file 0001193125-22-117641.txt   53055
Mailing Address 60 AVENUE ROCKEFELLER BATIMENT ADENINE LYON I0 69008
Business Address 60 AVENUE ROCKEFELLER BATIMENT ADENINE LYON I0 69008 011-33-4-78-74-44-38
Erytech Pharma S.A. (Filer) CIK: 0001624422 (see all company filings)

IRS No.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38281 | Film No.: 22850069
SIC: 2836 Biological Products, (No Diagnostic Substances)